Cost-Consequence Analysis of Deprescribing to Optimize Health Outcomes for Frail Older People: A Within-Trial Analysis

Overview of attention for article published in Journal of the American Medical Directors Association, January 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 28 X users
facebook: 2 Facebook pages

wikipedia: 1 Wikipedia page
guideline: 1 clinical guideline source

Readers on

mendeley: 33 Mendeley

So far, Altmetric has seen 37 X posts from 28 X users, with an upper bound of 44,757 followers.

RT @AmyTPage: Our health economic analysis of a deprescribing RCT in residential aged care finds it could save between $1m and $16m annuall…

RT @DeprescribeNet: Deprescribing can save money – with no reduction of quality of life: In this study, savings in medication costs per old…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 33 additional X posts.